ALPN - Alpine Immune Sciences Inc. (ALPN) CEO Mitchell Gold on Q3 2020 Results - Earnings Call Transcript
Alpine Immune Sciences, Inc. (ALPN) Q3 2020 Earnings Conference Call November 12, 2020 04:30 PM ET Company Participants Laurence Watts - Investor Relations Mitchell Gold - Chairman & Chief Executive Officer Stanford Peng - President & Head of Research & Development Paul Rickey - Chief Financial Officer Remy Durand - Senior Vice President, Business Development & Corporate Strategy Conference Call Participants Boris Peaker - Cowen Mark Breidenbach - Oppenheimer Ted Tenthoff - Piper Sandler Wangzhi Li - Ladenburg Presentation Operator Good afternoon, ladies and gentlemen. Thank you for joining the Alpine Immune Sciences' Third Quarter 2020 Financial Results and Corporate Update Conference Call. Currently, all participants are in a listen-only mode. Following management's prepared remarks, we will hold a Q&A session. [Operator Instructions] As a reminder, this conference is being recorded today, Thursday, November 12, 2020. I would now like to introduce Laurence Watts, Investor Relations. Please go ahead. Laurence
For further details see:
Alpine Immune Sciences, Inc. (ALPN) CEO Mitchell Gold on Q3 2020 Results - Earnings Call Transcript